Positron emitters for the study of tumor metabolism
Strauss, L.G.
Der Radiologe 29(7): 318-321
1989
ISSN/ISBN: 0033-832X PMID: 2667030 Document Number: 338324
Positron emission tomography with metabolically active substances is a noninvasive imaging modality to determine tumor metabolism. Quantification of tumor metabolism provides valuable information, e.g., for the differential diagnosis of malignancies. Radiolabeled therapeutic substances can be traced with PET. Measurement of fluorouracil metabolite concentrations provides data about the accumulation pattern of the cytostatic agent and allows assessment of the therapeutic outcome.
Document emailed within 1 workday
Related Documents
Paul, R.; Wendelin, H. 1984: Positron emitters and PET--current possibilities in isotope studies Duodecim; Laaketieteellinen Aikakauskirja 100(21): 1355-1358Qaim, S.M. 2008: Decay data and production yields of some non-standard positron emitters used in PET Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 52(2): 111-120
Wijsman, R.; Kaanders, J.H.; Oyen, W.J.; Bussink, J. 2013: Hypoxia and tumor metabolism in radiation oncology: targets visualized by positron emission tomography Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 57(3): 244-256
Kushner, M.J.; Rosenquist, A.; Alavi, A.; Rosen, M.; Dann, R.; Fazekas, F.; Bosley, T.; Greenberg, J.; Reivich, M. 1988: Cerebral metabolism and patterned visual stimulation: a positron emission tomographic study of the human visual cortex Neurology 38(1): 89-95
McKee, J.S.; Durocher, J.J.; Bose, R.; Gusdal, M.I.; Sharma, G.P.; Pinsky, C.; Gallop, D. 1985: Dynamic studies of positron-emitting putative tumor marker 132Cs in mice show differential tumor and regional uptake Cancer Detection and Prevention 8(1-2): 87-93
Kobayashi, N.; Fujita, K.; Fujisawa, T.; Takahashi, H.; Yoneda, M.; Abe, Y.; Inamori, M.; Kirikoshi, H.; Kubota, K.; Saito, S.; Nakajima, A. 2008: Which is the best monitoring study (tumor marker, computed tomography or 18F-fluoro-2-deoxy-D-glucose positron emission tomography) to evaluate efficacy of chemotherapy on unresectable pancreatic cancer ? Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(1): 65-70
Schipper, J.H.; Schrader, M.; Arweiler, D.; Müller, S.; Sciuk, J. 1996: Positron emission tomography for primary tumor detection in lymph node metastases with unknown primary tumor Hno 44(5): 254-257
McMillin-Wood, J.B. 1985: Biochemical approaches to metabolism: application to positron-emission tomography Circulation 72(5 Part 2): Iv145-Iv150
Chizyński, K. 1996: Positron emission tomography for assessment of myocardial perfusion and metabolism Polski Tygodnik Lekarski 51(10-13): 182-183
Ueda, T.; Takagi, M. 2006: Cerebral hemodynamics and metabolism in patients with TIA using positron emission tomography Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 8): 297-302
Loken, M.K.; Hawkins, R.A.; Gupta, N.C.; Frick, M.P. 1989: Positron emission tomography (PET): a unique approach for the imaging of in vivo metabolism Nebraska Medical Journal 74(11): 333-339
M'Rabet, N.; Lotstra, F.; Goldman, S.; Delvenne, V.; Mendlewicz, J. 1991: Cerebral glucose metabolism in schizophrenia. Studies using positron-emission tomography Acta Psychiatrica Belgica 91(6): 311-326
Schober, O.; Meyer, G.J. 1989: Clinical use of positron emission tomography in tumor patients Zeitschrift für Gastroenterologie. Verhandlungsband 24: 152-154
Imahori, Y.; Sasajima, H.; Mineura, K.; Imahori, Y. 2005: Molecular imaging for brain tumor using positron emission tomography Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 9): 250-257
Hartvig, P.; Waldenström, A.; Wikström, G.; Zielinski, T.; Martinussen, H.J.; Carlsten, J.; Voipio-Pulkki, L.M.; Lundqvist, H.; Bjurling, P.; Någren, K. 1991: Metabolism of [1-11C]palmitate in the diabetic heart studied in a porcine model using positron emission tomography Acta Radiologica. Supplementum 376: 137-138
Taegtmeyer, H.; Mossberg, K.A.; Nguyêń, V.T. 1991: Positron labeled tracers. a window for the assessment of energy metabolism in heart and skeletal muscle Acta Radiologica. Supplementum 376: 40-44
Shen, Y.Y.; Su, C.T.; Chen, G.J.S.; Chen, Y.K.; Liao, A.C.F.; Tsai, F.S. 2003: The value of 18F-fluorodeoxyglucose positron emission tomography with the additional help of tumor markers in cancer screening Neoplasma 50(3): 217-221
Sakai, M.; Kato, H.; Saito, K.; Tanaka, N.; Inose, T.; Kimura, H.; Miyazaki, T.; Kuwano, H. 2008: Clinical applications of 18F-fluorodeoxyglucose positron emission tomography in gastrointestinal stromal tumor of the esophagus International Surgery 93(4): 209-213
Zhang, J.; Shen, K.; Lang, J. 2002: Study on chemotherapy-induced disorders of glucose metabolism in patients with malignant ovarian tumor Zhonghua Fu Chan Ke Za Zhi 37(8): 481-483
Schuhmacher, J.; Klivényi, G.; Matys, R.; Stadler, M.; Regiert, T.; Hauser, H.; Doll, J.; Maier-Borst, W.; Zöller, M. 1995: Multistep tumor targeting in nude mice using bispecific antibodies and a gallium chelate suitable for immunoscintigraphy with positron emission tomography Cancer Research 55(1): 115-123